We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are four stocks with buy rank and strong value characteristics for investors to consider today, November 9th:
Danaos Corporation (DAC - Free Report) : This containerships owner and operator has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising nearly 14% over the last 60 days.
Equitable Holdings, Inc. (EQH - Free Report) : This diversified financial services company has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 4.4% over the last 60 days.
Nomura Holdings, Inc. (NMR - Free Report) : This financial services provider has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 19.8% over the last 60 days.
Western Asset Mortgage Capital Corporation : This real estate investment trust has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 2% over the last 60 days.
Western Asset Mortgage Capital Corporation Price and Consensus
Western Asset Mortgage Capital has a price-to-earnings ratio (P/E) of 4.22, compared with 7.20 for the industry. The company possesses a Value Score of A.
Western Asset Mortgage Capital Corporation PE Ratio (TTM)
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Shutterstock
Top Ranked Value Stocks to Buy for November 9th
Here are four stocks with buy rank and strong value characteristics for investors to consider today, November 9th:
Danaos Corporation (DAC - Free Report) : This containerships owner and operator has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising nearly 14% over the last 60 days.
Danaos Corporation Price and Consensus
Danaos Corporation price-consensus-chart | Danaos Corporation Quote
Danaos Corp has a price-to-earnings ratio (P/E) of 1.33, compared with 3.40 for the industry. The company possesses a Value Score of A.
Danaos Corporation PE Ratio (TTM)
Danaos Corporation pe-ratio-ttm | Danaos Corporation Quote
Equitable Holdings, Inc. (EQH - Free Report) : This diversified financial services company has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 4.4% over the last 60 days.
Equitable Holdings, Inc. Price and Consensus
Equitable Holdings, Inc. price-consensus-chart | Equitable Holdings, Inc. Quote
Equitable Holdings has a price-to-earnings ratio (P/E) of 4.97, compared with 19.00 for the industry. The company possesses a Value Score of A.
Equitable Holdings, Inc. PE Ratio (TTM)
Equitable Holdings, Inc. pe-ratio-ttm | Equitable Holdings, Inc. Quote
Nomura Holdings, Inc. (NMR - Free Report) : This financial services provider has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 19.8% over the last 60 days.
Nomura Holdings, Inc. Price and Consensus
Nomura Holdings, Inc. price-consensus-chart | Nomura Holdings, Inc. Quote
Nomura Holdings has a price-to-earnings ratio (P/E) of 4.97, compared with 12.20 for the industry. The company possesses a Value Score of B.
Nomura Holdings, Inc. PE Ratio (TTM)
Nomura Holdings, Inc. pe-ratio-ttm | Nomura Holdings, Inc. Quote
Western Asset Mortgage Capital Corporation : This real estate investment trust has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 2% over the last 60 days.
Western Asset Mortgage Capital Corporation Price and Consensus
Western Asset Mortgage Capital Corporation price-consensus-chart | Western Asset Mortgage Capital Corporation Quote
Western Asset Mortgage Capital has a price-to-earnings ratio (P/E) of 4.22, compared with 7.20 for the industry. The company possesses a Value Score of A.
Western Asset Mortgage Capital Corporation PE Ratio (TTM)
Western Asset Mortgage Capital Corporation pe-ratio-ttm | Western Asset Mortgage Capital Corporation Quote
See the full list of top ranked stocks here.
Learn more about the Value score and how it is calculated here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>